Skip to main content
CRBU logo
CRBU
(NASDAQ)
Caribou Biosciences, Inc.
$2.00-- (--)
Loading... - Market loading

Caribou Biosciences (CRBU) Stock Price & Financial Analysis

Caribou Biosciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.97 - $2.04
52-Week High$3.54
52-Week Low$0.77
Open$1.98
Volume1.71M
Average Volume (3M)1.62M
Market Cap183.98M
Shares Outstanding93.39M
Price to Sales (P/S)16.49
Price to Book (P/B)1.51
EV/EBITDA-1.50
Revenue (TTM)11.16M
Net Income (TTM)-148.13M
Free Cash Flow (TTM)-112.35M
EPS (TTM)$-1.59
Profit Margin-1327.40%
Operating Margin-1220.49%
Return on Equity (ROE)-121.24%
Debt to Equity0.22
50-Day MA$1.97
200-Day MA$1.93
52-Week Change148.14%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Caribou Biosciences

What is the current stock price for CRBU?

As of the latest trading session, CRBU stock trades at $2.00. The 52-week range is $0.77–$3.54, with a day range of $1.97–$2.04.

What is the P/E ratio for CRBU?

The P/E ratio (Price-to-Earnings) for CRBU is shown in the Key Statistics section. This valuation metric helps compare Caribou Biosciences, Inc. to industry peers.

Does CRBU pay dividends?

Caribou Biosciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CRBU?

Based on 2 analysts, the consensus for CRBU is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CRBU?

Caribou Biosciences's market capitalization is $186.8M, classifying it as a micro-cap company. Caribou Biosciences operates in the Healthcare sector within the Biotechnology industry.